Pieris Pharmaceuticals, Inc. (PIRS) .
本页证实的标准:
SharesGrow 综合评分： 34/100 其中 1/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-43.73 | $5.83M | $-22.8M | -391% |
| 2017 | $-32.14 | $25.28M | $-17.65M | -69.8% |
| 2018 | $-40.32 | $29.1M | $-26.75M | -91.9% |
| 2019 | $-37.54 | $46.28M | $-23.76M | -51.3% |
| 2020 | $-54.67 | $29.32M | $-37.23M | -127% |
| 2021 | $-53.75 | $31.42M | $-43.37M | -138% |
| 2022 | $-33.71 | $25.9M | $-31.25M | -120.7% |
| 2023 | $-21.80 | $42.81M | $-24.54M | -57.3% |
| 2024 | $-7.83 | $0.00 | $-17.43M | - |
| 2025 | $-3.71 | $0.00 | $-41.72M | - |
